ADA Scientific Sessions 2026 Abstract

Oral Delivery of Semaglutide, Tirzepatide, and Retatrutide Formulated in Polymerized Ursodeoxycholic Acid (pUDCA) Nanoparticles (NP)

By Gerald Rea, John Lee, Edward J. Bastyr, M D. Michael

Experiments in animalsInterventions

The paper

Gerald Rea, John Lee, Edward J. Bastyr, M D. Michael

West Lafayette

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1697-P

doi.org/10.2337/db26-1697-p

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity